mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis

por Rama, Tiago Azenha, Moreira, André, Castells, Mariana
Publicado 2021

Supply of Antioxidants vs. Recruit Firefighters’ Cellular Immune Status: A Randomized Double-Blinded Placebo-Controlled Parallel-Group Trial

por Santos, José Augusto Rodrigues, Rama, Tiago Azenha, da Silva, Domingos José Lopes, Fernandes, Ricardo J., Zacca, Rodrigo
Publicado 2022

Case Report: Mastocytosis: The Long Road to Diagnosis

por Rama, Tiago Azenha, Martins, Diana, Gomes, Nuno, Pinheiro, Jorge, Nogueira, Ana, Delgado, Luís, Plácido, José Luís, Coimbra, Alice
Publicado 2021

COVID-19 Vaccination Is Safe among Mast Cell Disorder Patients, under Adequate Premedication

por Rama, Tiago Azenha, Miranda, Joana, Silva, Diana, Amaral, Luís, Castro, Eunice, Coimbra, Alice, Moreira, André, Plácido, José Luís
Publicado 2022

Mastocytosis presenting with mast cell‐mediator release‐associated symptoms elicited by cyclo oxygenase inhibitors: prevalence, clinical, and laboratory features

por Rama, Tiago Azenha, Morgado, José Mário, Henriques, Ana, Escribano, Luis, Alvarez‐Twose, Iván, Sanchez‐Muñoz, Laura, Moreira, André, Romão, José, Órfão, Alberto, Matito, Almudena
Publicado 2022

COVID-19 infection in patients with mast cell disorders including mastocytosis does not impact mast cell activation symptoms

por Giannetti, Matthew P., Weller, Emily, Alvarez-Twose, Iván, Torrado, Inés, Bonadonna, Patrizia, Zanotti, Roberta, Dwyer, Daniel F., Foer, Dinah, Akin, Cem, Hartmann, Karin, Rama, Tiago Azenha, Sperr, Wolfgang R., Valent, Peter, Teodosio, Cristina, Orfao, Alberto, Castells, Mariana
Publicado 2021